Burcon NutraScience Corporation (BRCNF)
| Market Cap | 12.45M -43.2% |
| Revenue (ttm) | 2.25M +556.9% |
| Net Income | -10.25M |
| EPS | -0.82 |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 7,340 |
| Open | 0.966 |
| Previous Close | n/a |
| Day's Range | 0.966 - 1.016 |
| 52-Week Range | 0.350 - 1.990 |
| Beta | 2.90 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 13, 2026 |
About Burcon NutraScience
Burcon NutraScience Corporation, together with its subsidiaries, provides plant-based proteins and ingredients for the food and beverage industry in Canada and the United States. The company offers peas, hempseed, sunflower, canola, fava, and soy proteins used in dairy alternatives, meat alternatives, snacks and cereals, diet product, ready-to-mix and ready-to-drink beverages, as well as in nutritional supplements such as meal replacement shakes, egg alternatives, non-dairy frozen desserts, ready-to-mix beverages, whipped toppings, nutrition ba... [Read more]
Financial Performance
In fiscal year 2026, Burcon NutraScience's revenue was 2.26 million, an increase of 493.78% compared to the previous year's 381,396. Losses were -14.25 million, 72.5% more than in 2025.
Financial numbers in CAD Financial StatementsNews
Burcon Announces Shareholder Meeting Results and Updates Commercial Guidance
Customer demand remains strong as Company accelerates investment in manufacturing infrastructure and reliability Vancouver, British Columbia--(Newsfile Corp. - September 24, 2026) - Burcon NutraScienc...
Burcon NutraScience Transcript: AGM 2026
The AGM covered board elections, approval of auditors, share option plan, and convertible debenture financing. Strategic focus is on scaling production to meet surging protein demand, with capital raised for facility upgrades and working capital. Facility reliability issues were addressed and resolved.
Burcon Announces Annual General and Special Meeting Date
Company upsizes convertible debenture financing from $8.1 million to $21 million following strong investor interest Vancouver, British Columbia--(Newsfile Corp. - September 4, 2026) - Burcon NutraScie...
Burcon NutraScience Earnings Call Transcript: Q1 2027
Q1 revenue surged 54% sequentially to CAD 1.3 million, with over 40 active customers and strong repeat orders. Growth is driven by high-purity protein demand, capacity expansion, and a new CAD 8.1 million financing to support scaling. Cash flow positivity is targeted by year-end.
Burcon NutraScience Registration statement: Q1 2027
Burcon NutraScience filed a registration statement on August 12, 2026, providing details about a securities offering with the SEC.
Burcon NutraScience Registration statement: Q1 2027
Burcon NutraScience filed a registration statement on August 12, 2026, providing details about a securities offering with the SEC.
Burcon NutraScience Earnings release: Q1 2027
Burcon NutraScience released its Q1 2027 earnings on August 12, 2026, summarizing the period's financial results.
Burcon Reports Fiscal 2027 First Quarter Results, Advances Commercial Revenue Ramp
Revenue of $1.3 million, up 273% year-over-year and 54% sequentially Vancouver, British Columbia--(Newsfile Corp. - August 12, 2026) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon...
Burcon Announces Fiscal Year 2027 First Quarter Conference Call and Presentation to be Held on August 12, 2026
Vancouver, British Columbia--(Newsfile Corp. - August 7, 2026) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in plant-based protein...
Burcon NutraScience Earnings Call Transcript: Q4 2026
Revenue surged nearly sixfold to CAD 2.3 million in fiscal 2026, with double-digit quarter-over-quarter growth and expanding repeat customer sales. Operational milestones included scaling production, launching three new proteins, and achieving record output, positioning for continued strong growth into fiscal 2027.
Burcon NutraScience Registration statement: Q4 2026
Burcon NutraScience filed a registration statement on June 24, 2026, providing details about a securities offering with the SEC.
Burcon NutraScience Registration statement: Q4 2026
Burcon NutraScience filed a registration statement on June 24, 2026, providing details about a securities offering with the SEC.
Burcon NutraScience Earnings release: Q4 2026
Burcon NutraScience released its Q4 2026 earnings on June 24, 2026, summarizing the period's financial results.
Burcon Announces Fiscal 2026 Results
Vancouver, British Columbia--(Newsfile Corp. - June 24, 2026) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in plant-based protein ...
Burcon Announces Fiscal Year 2026 Conference Call and Presentation to be Held on June 24, 2026
Vancouver, British Columbia--(Newsfile Corp. - June 19, 2026) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in plant-based protein ...
Burcon Accelerates Growth & Achieves New Production Record
Advancing Burcon's commercialization journey through growing commercial traction and manufacturing scale Vancouver, British Columbia--(Newsfile Corp. - June 16, 2026) - Burcon NutraScience Corporation...
Burcon Announces Appointment of New Director
Vancouver, British Columbia--(Newsfile Corp. - April 29, 2026) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) (the "Burcon" or the "Company"), a global technology leader in plant-based pro...
Burcon Closes Final Tranche of Non-Brokered Private Placement of Convertible Debentures of up to $6.9 Million
Vancouver, British Columbia--(Newsfile Corp. - April 27, 2026) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in plant-based protein...
Burcon Achieves Record Production, Expands to More than 20 Buying Customers and Evaluates Additional Capacity Expansion
Vancouver, British Columbia--(Newsfile Corp. - April 20, 2026) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in plant-based protein...
Burcon Closes Second Tranche of Non-Brokered Private Placement of Convertible Debentures of up to $6.9 Million
Vancouver, British Columbia--(Newsfile Corp. - February 27, 2026) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in plant-based prot...
Burcon Announces Results of Shareholder Meeting
Vancouver, British Columbia--(Newsfile Corp. - February 20, 2026) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) (the "Burcon" or the "Company"), a global technology leader in plant-based ...
Stonegate Updates Coverage on Burcon Nutrascience Corporation (BU) FY26 Q3
Dallas, Texas--(Newsfile Corp. - February 12, 2026) - Burcon Nutrascience Corporation (TSX: BU): Stonegate Capital Partners updates their coverage on Burcon Nutrascience Corporation (TSX: BU). Burcon'...
Burcon NutraScience Earnings Call Transcript: Q3 2026
Q3 revenue doubled sequentially, meeting 2025 guidance, with strong recurring sales and over 200 customer projects. Double-digit revenue growth and cash flow positivity are reaffirmed for 2026, supported by a robust sales funnel and recent financing to accelerate capacity and growth.
Burcon NutraScience Earnings release: Q3 2026
Burcon NutraScience released its Q3 2026 earnings on February 11, 2026, summarizing the period's financial results.
Burcon NutraScience Registration statement: Q3 2026
Burcon NutraScience filed a registration statement on February 11, 2026, providing details about a securities offering with the SEC.